ScienceDex / Researcher record
Burgard, Edward
- Dignify Therapeutics, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2019 | $901,425 | 1 | #9,314 |
| 2021 | $1,187,722 | 1 | #7,448 |
| 2023 | $541,896 | 2 | #22,554 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20191 record
- FY20211 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing Burgard, Edward as a PI. Multi-PI records show the full award amount for context.
- 1U44NS129628-01U44Contact PIPreclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding$499.4Kaward amount
- 3U44NS129628-01S1U44Contact PIPreclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding$42.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Burgard, Edward as a PI.
FY2023 award administered by Dignify Therapeutics, LLC (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardDignify Therapeutics, LLC
- 2019$500K Cumulative Funding
- 2019Entered Top 50% NationallyRanked #9314
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding